JP2020142980A
|
|
Method for producing molybdenum nitride and composite molybdenum nitride
|
JP2021006497A
|
|
Method for producing low-defect carbon material
|
JP2020092693A
|
|
Method for evaluating immunosuppressive action or immune tolerance-inducing action, and immune tolerance inducer
|
JP2020033341A
|
|
Manufacturing method of radioactive fluorine labeling compound, and manufacturing method of radioactive pharmaceutical composition
|
JP2020185551A
|
|
Information processor, information processing method, and program
|
JP2020185223A
|
|
Monochrome ct image creation method, monochrome ct image creation device and monochrome ct image creation program
|
JP2020170429A
|
|
Gap change detection device, gap change detection method, and gap change detection program
|
JP2020167940A
|
|
Method and kit for evaluating late-stage recurrence risk of breast cancer
|
JP2020100893A
|
|
Copper cluster, mixed particles, conductive paste, and conductive ink
|
JP2020137505A
|
|
Nucleic acid probe sets for detecting ikzf1 gene mutation and methods for detecting ikzf1 gene mutation using the probe sets
|
JP2020139047A
|
|
Cellulose acetate film
|
JP2020138159A
|
|
Method and device producing water concentrated with d2o and/or hdo
|
JP2020137485A
|
|
Enzyme agent for epimerization catalyst of sugar, method for producing epimerization reaction product and epimerization reaction product
|
JP2020139770A
|
|
Diagnostic index of parkinson disease
|
JP2020130140A
|
|
Blood ccl11 concentration reducing agent containing royal jelly or processed product thereof as active ingredient
|
JP2020128901A
|
|
Device to diagnose degraded condition of rubber material
|
JP2020128900A
|
|
Method, system and program for estimating properties of rubber material
|
JP2020121946A
|
|
Type i interferon production inhibitor containing organic germanium compound as active ingredient
|
JP2020121928A
|
|
Circularly polarized luminescent rare earth complex
|
JP2020111553A
|
|
Pharmaceutical composition, and cancer therapy agent screening method
|